AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Propanc Biopharma, Inc.

$1.84 -$141.06 (-98.71%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$2.11
Day Range
$1.79$2.13
Year Range
$1.79$315.00
Market Cap
1.9M
AVG Volume
203.38K
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD) · A
-60M-40M-20M02017201820192020202120222023202420252026
PPCB Net Income (USD) by year
PeriodNet Income (USD)
2026-18.86M
2025-58.92M
2024-1.82M
2023-2.66M
2022-2.66M
2021-2.03M
2020-4.74M
2019-5.76M
2018-7.04M
2017-7.87M
Operating Income (USD) · A
-60M-40M-20M02017201820192020202120222023202420252026
PPCB Operating Income (USD) by year
PeriodOperating Income (USD)
2026-18.19M
2025-57.28M
2024-1.54M
2023-1.78M
2022-1.99M
2021-1.81M
2020-3.49M
2019-2.61M
2018-3.96M
2017-5.74M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: PPCB

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

Propanc Biopharma, Inc.
PPCB
Stockpicker

Video analysis: PPCB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PPCB

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.